Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY Year:2018 | Volume:27 | Issue:11 Page(s): 1239-1248

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France

Author(s)

| Issue Writer Certificate

Keywords

Not Registered.

Abstract

Cites

The Effect of Baclofen on the Reduction of the Level of Consciousness: A Case Report

References

No record.

Cite

APA: Copy

. (2018). Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 27(11), 1239-1248. SID. https://sid.ir/paper/743677/en

Vancouver: Copy

. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY[Internet]. 2018;27(11):1239-1248. Available from: https://sid.ir/paper/743677/en

IEEE: Copy

, “Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France,” PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, vol. 27, no. 11, pp. 1239–1248, 2018, [Online]. Available: https://sid.ir/paper/743677/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops